中文 | ENG

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................

第58卷 第1期 2025-1
Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature

.........................

第58卷 第1期 2025-1
The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma

.........................

第58卷 第1期 2025-1
Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study

.........................

第58卷 第1期 2025-1
Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale

.........................

第58卷 第1期 2025-1
Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer

.........................

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................
登入帳號才能閱讀全文
 
篇名 Protection of small bowel from ischemia and re-perfusion injury using luminal fetal bovine serum perfusion
作者 Wen-tsung Hung, Chia-Lang Fang, Chien-Ts Chu, Jyy-Jih Tsai-Wu
卷期/出版年月 35卷5期 (2002/10)
頁次 235-240
摘要 A fetal or newborn (rat) organ (eg intestine, kidney, skin or lung) transplanted into a syngenic adult host without any vascular anastomosis is able to survive. We hypothesize that fetal tissue possesses an innate ability to prevent ischemia reperfusion injury, such “factors” being developed during pregnancy. We created an ezperimental model to induce total vascular occlusion in a 15-cm long rat ileal segment. Using an osmotic minipump implanted at the subcutaneous space of the abdominal wall of a test rat, fetal bovine serum (FBS) luminal perfision was conducted. Three days prior to the three-hour total vascular occlusion and been induced, luminal perfusion using FBS commenced for the test animals. On day zero, day three and day six following the release of vascular occlusion, the test rats were sacrificed and tissue samp;es were obtained for morphological study and intestinal DNA and protien content measurement. We used a scale where the occlusion-induced morphological changes to the intestinal mucosa were graded into one of six different levels of mucosal damage. The greater the numerical rating, the more substantial morphological changes to the gut wall. On day zero, the mean grades of the morphologically apparent intestinal deterioration were both rated at a level of five for the control and the experimental group. The mean values were 3.1 and 2.1 on day three, and 2.6 and 1.5 on day six, for the control and experimental groups respectively. DNA content of the ischemically damaged ileal segment of control group was 2.26±0.52 (μg/mg) on day zero, 3.46±0.68 (μg/mg) on day 3 and 3.50±0.72(μg/mg) on day 6. DNA content of the experimental group on day xero was 2.79±0.78(μg/mg), 4.45±0.76(μg/mg) on day 3 and 4.49±0.49(μg/mg) on day 6. Protein content of the control group on day zero was 31.52±2.96(μg/mg), 54.85±4.16(μg/mg) on day 3 and 56.12±3.93(μg/mg) on day 6. Protein content of the experimental group was 57.93±5.48(μg/mg) on day zero, 74.69±9.50(μg/mg) on day 3 and 71.72±7.02(μg/mg) on day 6. From the data described above, luminal perfusion using FBS could, under certain circumstances, protect the small bowel from ischemia and reperfusion injury and also increase intestinal mass.
關鍵詞 Fetal bovine serum, ischemia-reperfusion injury
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw